Nipro exit from troubled Bipha JV may smooth Mitsubishi Tanabe blood product rejig
This article was originally published in Scrip
Executive Summary
The Japanese blood product operation Bipha will once again become a wholly owned subsidiary of Mitsubishi Tanabe Pharma (MTP) following a decision by long-time partner Nipro Corp to divest its interest in the joint venture.